Mechanisms of Resistance to Small Molecules in Acute Myeloid Leukemia

SIMPLE SUMMARY: Acute myeloid leukemia (AML) is a dangerous cancer of the blood. In recent years, a series of drugs was approved to specifically target misdirected processes in the cancerous cells. These so-called “small molecules” substantially improved therapeutic outcomes, but eventually leukemia...

Descripción completa

Detalles Bibliográficos
Autores principales: Lang, Tonio Johannes Lukas, Damm, Frederik, Bullinger, Lars, Frick, Mareike
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526197/
https://www.ncbi.nlm.nih.gov/pubmed/37760544
http://dx.doi.org/10.3390/cancers15184573

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526197/
https://www.ncbi.nlm.nih.gov/pubmed/37760544
http://dx.doi.org/10.3390/cancers15184573

Ejemplares similares